Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine

被引：0
|
作者：
Bruce Green
Herta Crauwels
Thomas N. Kakuda
Simon Vanveggel
Anne Brochot
机构：
[1] Model Answers Pty Ltd,
[2] Janssen R&D,undefined
[3] Alios BioPharma,undefined
来源：
Clinical Pharmacokinetics | 2017年 / 56卷
关键词：
Total Body Weight; Darunavir; Population Pharmacokinetic Model; Maraviroc; Etravirine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 536
页数：11
相关论文
共 50 条
  • [1] Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine
    Green, Bruce
    Crauwels, Herta
    Kakuda, Thomas N.
    Vanveggel, Simon
    Brochot, Anne
    CLINICAL PHARMACOKINETICS, 2017, 56 (05) : 525 - 536
  • [2] Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics
    Kirchheiner, J
    Müller, G
    Meineke, I
    Wernecke, KD
    Roots, I
    Brockmöller, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) : 459 - 466
  • [3] CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects
    Yin, OQP
    Tomlinson, B
    Chow, MSS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) : 370 - 377
  • [4] Impacts of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide in Chinese subjects
    Zhang, Yifan
    Chen, Xiaoyan
    Lin, Nan
    Zhong, Dafang
    Si, Dayong
    Gu, Yingjie
    Zhou, Hui
    DRUG METABOLISM REVIEWS, 2006, 38 : 161 - 162
  • [5] Impact of Genetic Polymorphisms in CYP2C9 and CYP2C19 on the Pharmacokinetics of Clinically Used Drugs
    Hirota, Takeshi
    Eguchi, Shunsuke
    Ieiri, Ichiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (01) : 28 - 37
  • [6] Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis
    Ercan, B.
    Ayaz, L.
    Cicek, D.
    Tamer, L.
    CELL BIOCHEMISTRY AND FUNCTION, 2008, 26 (03) : 309 - 313
  • [7] Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations
    Flores-Gutierrez, Sara
    Rodriguez-Larralde, Alvaro
    Vivenes de Lugo, Merlyn
    Castro de Guerra, Dinorah
    ANNALS OF HUMAN BIOLOGY, 2017, 44 (02) : 191 - 198
  • [8] Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
    Zhang, Yifan
    Si, Dayong
    Chen, Xiaoyan
    Lin, Nan
    Guo, Yingjie
    Zhou, Hui
    Zhong, Dafang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (01) : 67 - 74
  • [9] Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
    Kang, Pureum
    Cho, Chang-Keun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    Choi, Chang-Ik
    Bae, Jung-Woo
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (05) : 438 - 447
  • [10] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Tan, Bo
    Zhang, Yi-Fan
    Chen, Xiao-Yan
    Zhao, Xiao-Hua
    Li, Guo-Xin
    Zhong, Da-Fang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (02) : 145 - 151
12345